Drug General Information
Drug ID
D09OGW
Former ID
DNC014328
Drug Name
4'-(4-Nitrobenzensulfonamide)-4-hydroxychalcone
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530713]
Structure
Download
2D MOL

3D MOL

Formula
C21H16N2O6S
Canonical SMILES
C1=CC(=CC=C1C=CC(=O)C2=CC=C(C=C2)NS(=O)(=O)C3=CC=C(C=C3<br />)[N+](=O)[O-])O
InChI
1S/C21H16N2O6S/c24-19-10-1-15(2-11-19)3-14-21(25)16-4-6-17(7-5-16)22-30(28,29)20-12-8-18(9-13-20)23(26)27/h1-14,22,24H/b14-3+
InChIKey
WQIGNJDEMJBAFL-LZWSPWQCSA-N
PubChem Compound ID
Target and Pathway
Target(s) Tyrosine oxidase Target Info Inhibitor [530713]
BioCyc Pathway (S)-reticuline biosynthesis
Eumelanin biosynthesis
L-dopachrome biosynthesis
KEGG Pathway Tyrosine metabolism
Riboflavin metabolism
Metabolic pathways
Melanogenesis
PathWhiz Pathway Riboflavin Metabolism
Tyrosine Metabolism
WikiPathways Dopamine metabolism
References
Ref 530713Eur J Med Chem. 2010 May;45(5):2010-7. Epub 2010 Jan 28.Evaluation of anti-pigmentary effect of synthetic sulfonylamino chalcone.
Ref 530713Eur J Med Chem. 2010 May;45(5):2010-7. Epub 2010 Jan 28.Evaluation of anti-pigmentary effect of synthetic sulfonylamino chalcone.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.